Breaking News Instant updates and real-time market news.

TROW

T. Rowe Price

$143.56 /

-2.02 (-1.39%)

09:06
12/01/20
12/01
09:06
12/01/20
09:06

T. Rowe Price global headquarters to move to Harbor Point

T. Rowe Price announced that it has signed a letter of intent for a long-term lease in Harbor Point that will keep its global headquarters in downtown Baltimore. The firm plans to relocate its downtown Baltimore operations in 2024 to two modern, green buildings at Harbor Point that will be constructed to the firm's specifications, allowing it to create customized space that best meets its needs and supports the firm's collaborative culture.

TROW T. Rowe Price
$143.56 /

-2.02 (-1.39%)

11/19/20 BofA
T. Rowe Price downgraded to Neutral from Buy at BofA
11/19/20 BofA
T. Rowe Price downgraded to Neutral from Buy at BofA
11/11/20 Deutsche Bank
T. Rowe Price price target raised to $150 from $145 at Deutsche Bank
07/30/20 Wells Fargo
T. Rowe Price price target raised to $78 from $72 at Wells Fargo

TODAY'S FREE FLY STORIES

Options
Teva call volume above normal and directionally bullish » 11:05
01/19/21
01/19
11:05
01/19/21
11:05
TEVA

Teva

$12.60 /

+0.64 (+5.35%)

Bullish option flow…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TEVA Teva
$12.60 /

+0.64 (+5.35%)

TEVA Teva
$12.60 /

+0.64 (+5.35%)

12/21/20 Gabelli
Teva named 'Best Idea for 2021' at Gabelli
11/27/20 H.C. Wainwright
Corcept Therapeutics price target raised to $32 from $22 at H.C. Wainwright
11/24/20 Oppenheimer
Teva initiated with a Perform at Oppenheimer
11/23/20 Citi
Citi recommends pair trade of overweight Endo, underweight Teva
TEVA Teva
$12.60 /

+0.64 (+5.35%)

TEVA Teva
$12.60 /

+0.64 (+5.35%)

TEVA Teva
$12.60 /

+0.64 (+5.35%)

TEVA Teva
$12.60 /

+0.64 (+5.35%)

Periodicals
Instagram's Mosseri says removing Trump was the right decision, Verge says » 11:03
01/19/21
01/19
11:03
01/19/21
11:03
FB

Facebook

$254.71 /

+3.18 (+1.26%)

Instagram head Adam…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FB Facebook
$254.71 /

+3.18 (+1.26%)

FB Facebook
$254.71 /

+3.18 (+1.26%)

10:13 Today JPMorgan
JPMorgan says buy 'FANG' stocks amid 'fatigue and frustration'
09:52 Today
Fly Intel: Top five analyst upgrades
07:28 Today KeyBanc
Facebook price target raised to $345 from $340 at KeyBanc
05:02 Today BMO Capital
Facebook upgraded to Outperform from Market Perform at BMO Capital
FB Facebook
$254.71 /

+3.18 (+1.26%)

FB Facebook
$254.71 /

+3.18 (+1.26%)

FB Facebook
$254.71 /

+3.18 (+1.26%)

FB Facebook
$254.71 /

+3.18 (+1.26%)

Hot Stocks
Keysight's edge-to-core portfolio selected by Radisys » 11:02
01/19/21
01/19
11:02
01/19/21
11:02
KEYS

Keysight Technologies

$147.91 /

+1.64 (+1.12%)

Keysight Technologies…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
KEYS Keysight Technologies
$147.91 /

+1.64 (+1.12%)

KEYS Keysight Technologies
$147.91 /

+1.64 (+1.12%)

01/15/21 UBS
Keysight Technologies price target raised to $170 from $145 at UBS
01/14/21 Barclays
Keysight Technologies price target raised to $161 from $135 at Barclays
11/19/20 Baird
Keysight Technologies price target raised to $126 from $112 at Baird
11/19/20 Barclays
Keysight Technologies price target raised to $135 from $128 at Barclays
KEYS Keysight Technologies
$147.91 /

+1.64 (+1.12%)

KEYS Keysight Technologies
$147.91 /

+1.64 (+1.12%)

KEYS Keysight Technologies
$147.91 /

+1.64 (+1.12%)

Hot Stocks
Urban One trading resumes  11:00
01/19/21
01/19
11:00
01/19/21
11:00
UONE

Urban One

$5.71 /

-0.19 (-3.22%)

 
ShowHide Related Items >><<
UONE Urban One
$5.71 /

-0.19 (-3.22%)

Hot Stocks
Reading International trading resumes  10:57
01/19/21
01/19
10:57
01/19/21
10:57
 
Options
TJX put volume heavy and directionally bearish » 10:55
01/19/21
01/19
10:55
01/19/21
10:55
TJX

TJX

$67.52 /

-0.985 (-1.44%)

Bearish flow noted in TJX…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TJX TJX
$67.52 /

-0.985 (-1.44%)

TJX TJX
$67.52 /

-0.985 (-1.44%)

01/04/21 JPMorgan
TJX price target raised to $74 from $70 at JPMorgan
12/30/20 Guggenheim
TJX price target raised to $78 from $70 at Guggenheim
12/14/20
Citi strategist removes TJX from 'Recommended List'
12/11/20
Fly Intel: Top five analyst downgrades
TJX TJX
$67.52 /

-0.985 (-1.44%)

TJX TJX
$67.52 /

-0.985 (-1.44%)

TJX TJX
$67.52 /

-0.985 (-1.44%)

TJX TJX
$67.52 /

-0.985 (-1.44%)

Conference/Events
Newborn Acquisition Corp. management to meet virtually with Roth Capital » 10:54
01/19/21
01/19
10:54
01/19/21
10:54
NBAC

Newborn Acquisition Corp.

$18.09 /

+0.12 (+0.67%)

Virtual Meetings to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NBAC Newborn Acquisition Corp.
$18.09 /

+0.12 (+0.67%)

Hot Stocks
Reading International trading halted, volatility trading pause  10:52
01/19/21
01/19
10:52
01/19/21
10:52
 
Recommendations
Yield10 Bioscience proof-of-concept validates pipeline, says H.C. Wainwright » 10:52
01/19/21
01/19
10:52
01/19/21
10:52
YTEN

Yield10 Bioscience

$15.01 /

+1.51 (+11.19%)

After Yield10 Bioscience…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
YTEN Yield10 Bioscience
$15.01 /

+1.51 (+11.19%)

YTEN Yield10 Bioscience
$15.01 /

+1.51 (+11.19%)

09/10/20 H.C. Wainwright
Yield10 Bioscience initiated with a Buy at H.C. Wainwright
08/27/20 National Securities
Yield10 Bioscience upgraded to Buy from Neutral at National Securities
YTEN Yield10 Bioscience
$15.01 /

+1.51 (+11.19%)

YTEN Yield10 Bioscience
$15.01 /

+1.51 (+11.19%)

Hot Stocks
Urban One trading halted, volatility trading pause  10:50
01/19/21
01/19
10:50
01/19/21
10:50
UONE

Urban One

$5.71 /

-0.19 (-3.22%)

 
ShowHide Related Items >><<
UONE Urban One
$5.71 /

-0.19 (-3.22%)

Recommendations
Merus price target raised to $32 from $19 at Roth Capital » 10:50
01/19/21
01/19
10:50
01/19/21
10:50
MRUS

Merus

$23.61 /

+0.29 (+1.24%)

, LLY

Eli Lilly

$195.53 /

+4.68 (+2.45%)

Roth Capital analyst Tony…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MRUS Merus
$23.61 /

+0.29 (+1.24%)

LLY Eli Lilly
$195.53 /

+4.68 (+2.45%)

MRUS Merus
$23.61 /

+0.29 (+1.24%)

09/02/20 Roth Capital
Roth Capital keeps Buy on Merus after delay of cancer data
06/26/20 H.C. Wainwright
Merus initiated with a Buy at H.C. Wainwright
05/27/20
Fly Intel: Top five analyst downgrades
05/27/20 RBC Capital
Merus downgraded to Sector Perform from Outperform at RBC Capital
LLY Eli Lilly
$195.53 /

+4.68 (+2.45%)

09:52 Today
Fly Intel: Top five analyst upgrades
06:14 Today Mizuho
Eli Lilly upgraded to Buy from Neutral at Mizuho
01/12/21 Truist
Eli Lilly price target raised to $200 from $182 at Truist
01/11/21 JPMorgan
Alzheimer's data a 'significant positive' for Eli Lilly story, says JPMorgan
MRUS Merus
$23.61 /

+0.29 (+1.24%)

LLY Eli Lilly
$195.53 /

+4.68 (+2.45%)

LLY Eli Lilly
$195.53 /

+4.68 (+2.45%)

MRUS Merus
$23.61 /

+0.29 (+1.24%)

LLY Eli Lilly
$195.53 /

+4.68 (+2.45%)

LLY Eli Lilly
$195.53 /

+4.68 (+2.45%)

Conference/Events
G1 Therapeutics management to meet virtually with Roth Capital » 10:49
01/19/21
01/19
10:49
01/19/21
10:49
GTHX

G1 Therapeutics

$21.00 /

+0.18 (+0.86%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GTHX G1 Therapeutics
$21.00 /

+0.18 (+0.86%)

GTHX G1 Therapeutics
$21.00 /

+0.18 (+0.86%)

11/17/20 Raymond James
Raymond James downgrades G1 Therapeutics after removing rintodestrant from model
11/17/20 Raymond James
G1 Therapeutics downgraded to Outperform from Strong Buy at Raymond James
07/01/20 Wedbush
G1 Therapeutics price target lowered to $50 from $55 at Wedbush
06/26/20 Roth Capital
G1 Therapeutics initiated with a Buy at Roth Capital
GTHX G1 Therapeutics
$21.00 /

+0.18 (+0.86%)

Downgrade
Xerox downgraded to Sell at Cross Research on work from home headwinds » 10:48
01/19/21
01/19
10:48
01/19/21
10:48
XRX

Xerox

$21.60 /

-0.89 (-3.96%)

Cross Research analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
XRX Xerox
$21.60 /

-0.89 (-3.96%)

XRX Xerox
$21.60 /

-0.89 (-3.96%)

09:58 Today Cross Research
Xerox downgraded to Sell from Hold at Cross Research
12/16/20 Morgan Stanley
Xerox price target raised to $24 from $17 at Morgan Stanley
10/13/20 Morgan Stanley
Morgan Stanley upgrades IT Hardware industry view to Attractive from In-Line
07/24/20
Fly Intel: Top five analyst downgrades
XRX Xerox
$21.60 /

-0.89 (-3.96%)

XRX Xerox
$21.60 /

-0.89 (-3.96%)

XRX Xerox
$21.60 /

-0.89 (-3.96%)

Options
Taiwan Semi call volume above normal and directionally bullish » 10:45
01/19/21
01/19
10:45
01/19/21
10:45
TSM

TSMC

$133.54 /

+8.28 (+6.61%)

Bullish option flow…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TSM TSMC
$133.54 /

+8.28 (+6.61%)

TSM TSMC
$133.54 /

+8.28 (+6.61%)

01/14/21 Needham
Intel upgraded to Buy from Hold at Needham
01/12/21
Fly Intel: Top five analyst upgrades
01/12/21 Bernstein
TSMC upgraded to Outperform from Market Perform at Bernstein
12/29/20 RBC Capital
Intel intraday move on Third Point news looks 'overdone,' says RBC Capital
TSM TSMC
$133.54 /

+8.28 (+6.61%)

TSM TSMC
$133.54 /

+8.28 (+6.61%)

TSM TSMC
$133.54 /

+8.28 (+6.61%)

TSM TSMC
$133.54 /

+8.28 (+6.61%)

General news
8-Week Bill Announcement to be released at 11:00  10:45
01/19/21
01/19
10:45
01/19/21
10:45
 
General news
4-Week Bill Announcement to be released at 11:00  10:45
01/19/21
01/19
10:45
01/19/21
10:45
 
General news
4-Week Bill Announcement to be released at 11:00  10:45
01/19/21
01/19
10:45
01/19/21
10:45
 
General news
8-Week Bill Announcement to be released at 11:00  10:45
01/19/21
01/19
10:45
01/19/21
10:45
 
Conference/Events
Zoetis management to meet virtually with William Blair » 10:40
01/19/21
01/19
10:40
01/19/21
10:40
ZTS

Zoetis

$163.52 /

+2.59 (+1.61%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ZTS Zoetis
$163.52 /

+2.59 (+1.61%)

ZTS Zoetis
$163.52 /

+2.59 (+1.61%)

11/12/20 Truist
Zoetis price target raised to $170 from $160 at Truist
11/06/20 Barclays
Zoetis price target raised to $189 from $175 at Barclays
09/21/20 Atlantic Equities
Zoetis initiated with an Overweight at Atlantic Equities
08/18/20 Argus
Elanco price target raised to $30 from $26 at Argus
ZTS Zoetis
$163.52 /

+2.59 (+1.61%)

ZTS Zoetis
$163.52 /

+2.59 (+1.61%)

Hot Stocks
Aclaris Therapeutics trading resumes  10:40
01/19/21
01/19
10:40
01/19/21
10:40
ACRS

Aclaris Therapeutics

$15.44 /

+9.58 (+163.48%)

 
ShowHide Related Items >><<
ACRS Aclaris Therapeutics
$15.44 /

+9.58 (+163.48%)

ACRS Aclaris Therapeutics
$15.44 /

+9.58 (+163.48%)

ACRS Aclaris Therapeutics
$15.44 /

+9.58 (+163.48%)

Hot Stocks
Greenrose Axquisition Corporation (Units) trading resumes  10:38
01/19/21
01/19
10:38
01/19/21
10:38
 
Hot Stocks
Aclaris Therapeutics trading halted, volatility trading pause  10:35
01/19/21
01/19
10:35
01/19/21
10:35
ACRS

Aclaris Therapeutics

$14.95 /

+9.09 (+155.12%)

 
ShowHide Related Items >><<
ACRS Aclaris Therapeutics
$14.95 /

+9.09 (+155.12%)

ACRS Aclaris Therapeutics
$14.95 /

+9.09 (+155.12%)

ACRS Aclaris Therapeutics
$14.95 /

+9.09 (+155.12%)

General news
FX Action: USD-JPY » 10:35
01/19/21
01/19
10:35
01/19/21
10:35

FX Action: USD-JPY has…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Hot Stocks
General Dynamics awarded $695M U.S. Army Europe contract » 10:34
01/19/21
01/19
10:34
01/19/21
10:34
GD

General Dynamics

$154.53 /

+1.28 (+0.84%)

General Dynamics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GD General Dynamics
$154.53 /

+1.28 (+0.84%)

GD General Dynamics
$154.53 /

+1.28 (+0.84%)

11/03/20 Morgan Stanley
Morgan Stanley sees attractive buying opportunity in Defense stocks
10/29/20 Credit Suisse
General Dynamics price target lowered to $140 from $156 at Credit Suisse
10/02/20
Fly Intel: Top five analyst downgrades
10/02/20 Baird
Baird downgrades General Dynamics, sees no 'material' Gulfstream ramp
GD General Dynamics
$154.53 /

+1.28 (+0.84%)

GD General Dynamics
$154.53 /

+1.28 (+0.84%)

GD General Dynamics
$154.53 /

+1.28 (+0.84%)

Hot Stocks
Alpha short Mesoblast, expects chronic lower back pain Phase 3 trial to fail » 10:33
01/19/21
01/19
10:33
01/19/21
10:33
MESO

Mesoblast

$9.48 /

-0.21 (-2.17%)

Alpha Exposure said in a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MESO Mesoblast
$9.48 /

-0.21 (-2.17%)

MESO Mesoblast
$9.48 /

-0.21 (-2.17%)

08:01 Today Jefferies
Mesoblast downgraded to Hold from Buy at Jefferies
12/22/20
Fly Intel: Top five analyst downgrades
12/22/20 Maxim
Mesoblast downgraded to Hold from Buy at Maxim
12/18/20 H.C. Wainwright
Mesoblast price target lowered to $16 from $20 at H.C. Wainwright
MESO Mesoblast
$9.48 /

-0.21 (-2.17%)

MESO Mesoblast
$9.48 /

-0.21 (-2.17%)

MESO Mesoblast
$9.48 /

-0.21 (-2.17%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.